DHX37 and hepatocellular carcinoma: In this study, we analyzed the expression of DHX37 in hepatic hepatocellular carcinoma (HCC), its correlation with clinicopathological features, potential prognostic value, and the effect of DHX37 expression on chemotherapy and immunotherapy of hepatocellular carcinoma by using bioinformatics tools such as GDSC, HPA, STRING, TISCH, and TIMER2.